WAILEA, Hawaii — At Hawaiian Eye 2018, John P. Berdahl, MD, discusses the steps to take to identify the reasons for an unhappy multifocal IOL patient and how to turn that patient into a happy patient.
WAILEA, Hawaii — At Hawaiian Eye 2018, Quentin B. Allen, MD, discusses supraciliary shunts to treat glaucoma in cataract surgery.
WAILEA, Hawaii — At Hawaiian Eye 2018, Nick Curtis, CEO of Lensar, discusses the company’s acquisition of Precision Eye Services and the impact it will have on their business.
WAILEA, Hawaii — At Hawaiian Eye 2018, Allison W. Shuren, MSN, JD, discusses the uptick in physicians being held individually liable at the federal and state level under the False Claims Act.
WAILEA, Hawaii — There are surgical and nonsurgical options for the management of patients who were implanted with a presbyopic IOL and have residual refractive error, according to Audrey Talley Rostov, MD.
“It’s important to meet patient expectations and have patient considerations [in mind],” Rostov said at Hawaiian Eye 2018.
Rostov recommends determining if the patient is functional and if there is any co-existing pathology. Understanding the best-corrected vision is also important.
Determine whether the refractive is stable or unstable. Be sure to carefully evaluate
WAILEA, Hawaii — A balance between safety and efficacy is needed when deciding whether to treat retinopathy of prematurity with bevacizumab or diode laser photocoagulation in premature newborns, a speaker here said.
Bevacizumab is a powerful suppressive agent given during a time when a lot of organ systems are developing, peaking in the systemic circulation around 2 weeks and lasting to about 8 weeks in systemic circulation, Darius M. Moshfeghi, MD, said at Retina 2018. Furthermore, neurodevelopmental abnormalities have been noted in small sick babies receiving bevacizumab in some
WAILEA, Hawaii — The combination of a scleral lens and autologous serum tears can effectively treat patients with refractory cases of persistent epithelial retinal defects, according to a speaker here.
“The PROSE (prosthetic replacement of the ocular surface ecosystem) lens has been a miracle for a lot of patients who haven’t responded to treatment for dry eye disease or some other form of ocular surface disease,” Kendall E. Donaldson, MD, MS, said at Hawaiian Eye 2018.
In a case series, three patients with persistent epithelial defects who were refractory after (Read more...)
WAILEA, Hawaii, and AMELIA ISLAND, Fla. — The Wyanoke Group, parent company of SLACK Incorporated, publisher of Ocular Surgery News, has acquired Cataract Surgery: Telling It Like It Is, from Robert H. Osher, MD, the meeting’s founder and program director.
Osher announced the agreement from the podium today during the meeting in Amelia Island, Fla. The agreement is effective with the 2019 meeting.
Osher will remain the meeting’s program director. Richard L. Lindstrom, MD, Ocular Surgery News’ Chief Medical Editor, will join the meeting program committee.
Osher created the
WAILEA, Hawaii — Myopic choroidal neovascularization, a continuum of myopia and pathologic myopia, is a rare but treatable cause of vision loss, according to a speaker here.
Approximately 41,000 people in the U.S. have myopic choroidal neovascularization (CNV). People with pathologic myopia between the ages of 45 and 64 years, especially women, are more likely to develop myopic CNV, Rishi P. Singh, MD, said at Retina 2018.
“We’re learning more about the primary prevention strategies, and I think the numbers will hopefully improve due to those strategies. I use OCT
Susan Thompson Hingle
Due to concerns about physician health, the ACP recently launched an initiative to cultivate a culture of wellness, enhance practice efficiency, reduce administrative burdens and improve physician well-being and professional satisfaction, according to a press release.
“Health care is experiencing unprecedented changes that threaten its survival,” Susan Thompson Hingle, MD, chair of ACP’s Board of Regents, told Healio Internal Medicine. “To successfully navigate these challenges, we need committed and productive physicians working in collaboration
In 2016, more than 63,000 people overdosed and died; opioids caused approximately 66% of those deaths, according to research from the CDC.
“To put that in perspective, 58,220 American service members died during the entire Vietnam War, which lasted from 1955 to 1975,” Michael Ashburn, MD, MPH, MBA, director of Pain Medicine and Palliative Care at Penn Medicine, told Healio. “The highest annual death rate attributed to AIDS was 43,000 in 1995. We are in the middle of a public health crisis, and need to dedicate much more (Read more...)
More than 100 medical societies, including the American College of Rheumatology, have urged Congress to reverse a recent CMS policy that applies Merit-based Incentive Payment System adjustments to Medicare Part B payments, warning that it will create massive financial uncertainty for specialty providers and endanger patient access.
In a letter addressed the Senate Finance on Committee, as well as the House Ways and Means and Energy and Commerce committees, the leaders of 109 medical societies argued that the new policy, included in CMS’ 2018 Quality Payment Program Final Rule, creates
WAILEA, Hawaii — At Hawaiian Eye 2018, Savak “Sev” Teymoorian, MD, MBA, discusses the importance of treating astigmatism in cataract surgery in patients with glaucoma.
WAILEA, Hawaii — At Retina 2018, Jay S. Duker, MD, discusses how to use OCT to diagnose disease in the peripheral part of the retina.
WAILEA, Hawaii — At Retina 2018, Audina M. Berrocal, MD, discusses how to identify retinoblastoma in pediatric retina cases.
WAILEA, Hawaii — Appropriate local therapy can work as well as systemic therapy for treatment of uveitis, according to a speaker.
“So much of uveitis happens in the draining lymph nodes and doesn’t happen in the eye,” Thomas A. Albini, MD, said at Retina 2018, which is a reason why uveitis specialists prefer systemic therapy.
However, beyond oral steroids, there are regional treatments: topical, sub-Tenon’s, intravitreal and sustained release.
Citing a study by Feiler et al. that evaluated short-term safety and efficacy of topical difluprednate for treatment of
WAILEA, Hawaii — At Hawaiian Eye 2018, Elizabeth Yeu, MD, discusses how changing demographics such as an aging population and dwindling number of ophthalmologists are necessitating a change in relationship between ophthalmologists and optometrists regarding patient care.
WAILEA, Hawaii — At Hawaiian Eye 2018, Mark S. Milner, MD, discusses an algorithm for diagnosing dry eye that will also help determine what treatments are appropriate in which patients.
WAILEA, Hawaii — At Hawaiian Eye 2018, Jeannine Mason, director of marketing for Quidel eye health, discusses the company’s entry into ophthalmology with Inflammadry and Adeno-plus diagnostics.
WAILEA, Hawaii — Andrew G. Lee, MD, received the Hawaiian Eye Comprehensive Program’s Speaker of the Day for Thursday.
Lee moderated the Neuro-Ophthalmology Session and spoke on “Neuro-ophthalmology: A Case-based Panel Approach,” with Randy H. Kardon, MD, PhD; and Grant T. Liu, MD.
William F. Mieler , MD, was awarded Speaker of the Day for Retina 2018. Meiler presented “Uveal Melanoma Update and Management of Complications.”
Kristine Lindgren, MA, PMP , received Speaker of the Day for the Administrator Program. Thursday was Organizational Development Day.